
Kevin Chan, OD, MS, discusses an AAOpt 2026 symposium on individualized low-dose atropine dosing for myopia and the FDA outlook ahead of the SYD-101 advisory meeting.
Kicking off AMD Awareness Month, give us your thoughts!
Have you recommended/referred a patient with AMD for a low vision evaluation






